Page 108 - 2019秋季手冊內頁-ebook測試
P. 108
Summary
• Clinicians need to recognize irAEs when initiate immunotherapy
• irAEs first line treatment is corticosteroids
• Unclear of which agents if steroid refractory
• Infliximab preferred if colitis
• Mycophenolate preferred if hepatitis • Specialty consultation
• Treatment with steroids do not appear to impact efficacy
• Should not impact decision to initiate therapy
109
